| GILDGILEAD SCIENCES, INC. | 1,670,288 | $232.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 186,388 | $144.0M |
| ONCBeOne Medicines Ltd. | 259,731 | $77.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 224,330 | $74.2M |
| INSMINSMED Inc | 401,735 | $65.7M |
| COGTCogent Biosciences, Inc. | 1,516,297 | $58.4M |
| RVMDREVOLUTION MEDICINES, INC. | 580,677 | $56.5M |
| ROIVRoivant Sciences Ltd. | 2,001,976 | $55.5M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 464,340 | $40.4M |
| NUVLNuvalent, Inc. | 391,306 | $40.1M |
| ARGXARGENX SE | 54,148 | $39.5M |
| IONSIONIS PHARMACEUTICALS INC | 484,053 | $36.3M |
| TERNTerns Pharmaceuticals, Inc. | 631,636 | $33.3M |
| INCYIncyte Corp. | 342,042 | $32.2M |
| SYRESpyre Therapeutics, Inc. | 610,282 | $30.8M |
| TNGXTango Therapeutics, Inc. | 1,269,246 | $26.6M |
| ARQTArcutis Biotherapeutics, Inc. | 1,086,651 | $25.6M |
| DFTXDefinium Therapeutics Inc. | 1,293,629 | $24.4M |
| ELVNEnliven Therapeutics, Inc. | 594,079 | $23.3M |
| CYTKCYTOKINETICS INC | 335,208 | $22.1M |
| DNLIDenali Therapeutics Inc. | 1,099,845 | $21.1M |
| BBIOBridgeBio Pharma, Inc. | 278,888 | $20.7M |
| ORKAOruka Therapeutics, Inc. | 411,006 | $20.2M |
| APGEApogee Therapeutics, Inc. | 223,541 | $18.8M |
| PCVXVaxcyte, Inc. | 315,022 | $18.3M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 213,522 | $17.9M |
| RCUSArcus Biosciences, Inc. | 790,613 | $17.1M |
| IMVTImmunovant, Inc. | 680,372 | $16.9M |
| STOKStoke Therapeutics, Inc. | 502,020 | $16.3M |
| MLTXMoonLake Immunotherapeutics | 818,126 | $15.2M |
| TEVATeva Pharmaceutical Industries Limited | 467,562 | $14.1M |
| VRDNViridian Therapeutics, Inc.\DE | 711,739 | $13.9M |
| MRNAModerna, Inc. | 230,824 | $11.7M |
| OLMAOlema Pharmaceuticals, Inc. | 759,513 | $11.3M |
| SRRKScholar Rock Holding Corp | 225,998 | $11.1M |
| TVTXTravere Therapeutics, Inc. | 369,995 | $11.0M |
| ATAIAtai Beckley N.V. | 3,086,379 | $10.9M |
| SMMTSummit Therapeutics Inc. | 540,662 | $10.3M |
| SIONSionna Therapeutics, Inc. | 236,813 | $9.5M |
| SLNOSOLENO THERAPEUTICS INC | 281,620 | $9.4M |
| CLDXCelldex Therapeutics, Inc. | 278,888 | $8.8M |
| MAZEMaze Therapeutics, Inc. | 278,167 | $8.3M |
| NRIXNurix Therapeutics, Inc. | 534,259 | $8.3M |
| IMCRImmunocore Holdings plc | 269,729 | $8.1M |
| OCULOCULAR THERAPEUTIX, INC | 949,216 | $8.0M |
| ORICOric Pharmaceuticals, Inc. | 574,085 | $7.3M |
| EXELEXELIXIS, INC. | 143,557 | $6.2M |
| GERNGERON CORP | 3,921,476 | $5.8M |
| BCAXBicara Therapeutics Inc. | 238,822 | $4.8M |
| ABVXAbivax SA | 36,061 | $4.0M |
| NBPNovaBridge Biosciences | 1,132,563 | $2.8M |
| FBRXForte Biosciences, Inc. | 84,803 | $2.2M |
| CNTACentessa Pharmaceuticals plc | 36,254 | $1.4M |